CRISPR Milestone and Gene Therapy Redefine the Curative Landscape of Beta-Thalassemia
A new review charts how stem cell transplantation, lentiviral gene therapy, and CRISPR-based editing such as Casgevy are turning beta-thalassemia ...
A new review charts how stem cell transplantation, lentiviral gene therapy, and CRISPR-based editing such as Casgevy are turning beta-thalassemia ...
A prospective Polish study shows that patients who develop graft-versus-host disease in the first six months after allogeneic stem cell ...
University of Zurich researchers found that a one-hour treatment with activated protein C keeps human blood stem cells in a ...
A new study of 209 female stem cell transplant survivors finds severe gaps in fertility knowledge despite nearly half desiring ...
A pediatric case report details the successful treatment of severe liver-predominant acute graft-versus-host disease after stem cell transplantation for beta-thalassemia ...
A case report in Annals of Hematology details how sequential stem cell and liver transplantation, supported by letermovir CMV prophylaxis ...
A national multicenter study of 132 Turkish children with first-relapsed acute lymphoblastic leukemia shows encouraging survival for standard-risk patients under ...
Researchers have shown that CRISPR base editors can correct three pathogenic Artemis mutations ex vivo with up to 50 percent ...
A nationwide Japanese study has found that growth hormone therapy can improve adult height in children who develop growth impairment ...
In a groundbreaking study published in BMC Cancer, researchers have unveiled promising advancements in the battle against high-risk acute myeloid ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine